Biochemistry, biology, and carcinogenicity of tobacco-specific N- nitrosamines

Chemical Research in Toxicology

Volumn 11, Issue 6, 1998, Pages 559-603

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITROSAMINE;

ANIMAL TISSUE; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DNA ADDUCT; DNA BINDING; DNA DAMAGE; DOSE RESPONSE; GENETIC TOXICOLOGY; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; RAT; REVIEW; STRUCTURE ANALYSIS; TOBACCO; XENOBIOTIC METABOLISM;

ANIMALS; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; GENES, P53; GENES, RAS; HEMOGLOBINS; HUMANS; LUNG NEOPLASMS; MUTATION; NITROSAMINES;

ANIMALIA; NICOTIANA TABACUM;

EID: 0031831381     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx980005y     Document Type: Review

References (445)

1. Magee, P. N., and Barnes, J. M. (1956) The production of malignant primary hepatic tumors in the rat by feeding dimetnylnitrosamine, Br. J. Cancer 10, 114-122.
2. Druckrey, H., Preussmann, R., Ivankovic, S., and Schmähl, D. (1967) Organotrope Carcinogen Wirkungen bei 65 verschiedenen N-Nitrosoverbindungen an BD-ratten. (Organotropic carcinogenic effects of 65 different N-nitroso compounds on BD-rats.) Z. Krebsforsch. 69, 103-201.
3. Preussmann, R., and Stewart, B. W. (1984) N-nitroso carcinogens. In Chemical Carcinogenesis (Searle, C. E., Ed.) pp 643-828, American Chemical Society, Washington, DC.
4. Lijinsky, W. (1992) Chemistry and Biology of N-Nitroso Compounds, Cambridge University Press, Cambridge, England.
5. Bogovski, P., and Bogovski, S, (1981) Animal species in which N-nitroso compounds induce cancer. Int. J. Cancer 27, 471-474.
6. Druckrey, H., and Preussmann, R. (1962) Zur Entstehung carcinogener Nitrosamine am Beispiel des Tabakruachs. (The formation of carcinogenic nitrosamines in tobacco, as an example.) Die Natur. 49, 488-499.
7. Boyland, E., Roe, F. J. C., and Gorrod, J. W. (1964) Induction of pulmonary tumours in mice by nitrosonornicotine, a possible constituent of tobacco smoke. Nature 202, 1126.
8. Boyland, E., Roe, F. J. C., Gorrod, J. W., and Mitchley, B. C. V. (1964) The carcinogenicity of nitrosoanabasine, a possible constituent of tobacco smoke. Br. J. Cancer 18, 265-270.
9. Hoffmann, D., Rathkamp, G., and Lui, Y. Y. (1974) On the isolation and identification of volatile and nonvolatile N-nitrosamines and hydrazines in cigarette smoke. N-Nitroso Compounds in the Environment, IARC Scientific Publ. No. 9, pp 159-165, International Agency for Research on Cancer, Lyon, France.
10. Hoffmann, D., Hecht, S. S., Ornaf, R. M., and Wynder, E. L. (1974) N′-nitrosonornicotine in tobacco. Science 186, 265-267.
11. Smith, P. A. S., and Loeppky, R. N. (1967) Nitrosative cleavage of tertiary amines. J. Am. Chem. Soc. 89, 1148-1152.
12. Klus, H., and Kuhn, H. (1975) Utersuchungen uber die nichtfluchtigen N-nitrosamine der tabakalkaloide. (Research on the non-volatile nitrosamines of tobacco alkaloids.) Fachliche Mitt. Austria Tabakwerke 16, 307-317.
13. Hecht, S. S., Chen, C. B., Dong, M., Ornaf, R. M., Hoffmann, D., and Tso, T. C. (1977) Studies on nonvolatile nitrosamines in tobacco. Beitr. Tabakforsch. 9, 1-6.
14. Hecht, S. S., Chen, C. B., and Hoffmann, D. (1976) Synthesis of N-nitrosamino aldehydes. Tetrahedron Lett. 8, 593-596.
15. Hecht, S. S., Chen, C. B., Ornaf, R. M., Jacobs, E., Adams, J. D., and Hoffmann, D. (1978) Reaction of nicotine and sodium nitrite: formation of nitrosamines and fragmentation of the pyrrolidine ring. J. Org. Chem. 43, 72-76.
16. Hecht, S. S., Chen, C. B., Hirota, N., Ornaf, R. M., Tso, T. C., and Hoffmann, D. (1978) Tobacco specific nitrosamines: formation from nicotine in vitro and during tobacco curing and carcinogenicity in strain A mice. J. Natl. Cancer Inst. 60, 819-824.
17. Hecht, S. S., Chen, C. B., Ohmori, T., and Hoffmann, D. (1980) Comparative carcinogenicity in F344 rats of the tobacco specific nitrosamines, N′-nitrosonornicotine and 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 40, 298-302.
18. International Agency for Research on Cancer. (1985) Tobacco habits other than smoking: betel quid and areca nut chewing and some related nitrosamines. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 37, International Agency for Research on Cancer, Lyon, France.
19. International Agency for Research on Cancer. (1986) Tobacco smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38, International Agency for Research on Cancer, Lyon, France.
20. Hoffmann, D., and Hecht, S. S. (1985) Nicotine-derived N-nitrosamines and tobacco related cancer: current status and future directions. Cancer Res. 45, 935-944.
21. Hecht, S. S., and Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 9, 875-884.
22. Hoffmann, D., Brunnemann, K. D., Prokopczyk, B., and Djordjevic, M. V. (1994) Tobacco-specific N-nitrosamines and arecaderived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Environ. Health 41, 1-52.
23. Spiegelhalder, B., and Bartsch, H. (1996) Tobacco-specific nitrosamines. Eur. J. Cancer Prev. 5, 33-38.
24. World Cancer Research Fund/American Institute for Cancer Research. (1997) Food, Nutrition and the Prevention of Cancer: a Global Perspective, Vol. 37.
25. Landis, S. H., Murray, T., Bolden, S., and Wingo, P. A. (1998) Cancer statistics, 1998. CA - Cancer J. Clin. 48, 6-29.
26. Anonymous. (1996) Cigarette smoking among adults - United States, 1994. MMWR 45, 588-590.
27. National Institutes of Health, National Cancer Institute. (1996) Changes in cigarette-related disease risks and their implication for prevention and control. Smoking and Tobacco Control Monograph 8, pp 13-112, NIH, Bethesda, MD.
28. Thun, M. J., Lilly, C. A., Flannery, J. T., Galle, E. E., Flanders, W. D., and Heath, C. W. (1997) Cigarette smoking and changes in the histopathology of lung cancer. J. Natl. Cancer Inst. 89, 1580-1586.
29. Shopland, D. R. (1995) Tobacco use and its contribution to early cancer mortality with a special emphasis on cigarette smoking. Environ. Health Perspect. 103 (Suppl. 8), 131-142.
30. Fuchs, C. S., Colditz, G. A., Stampfer, M. J., Giovannucci, E. L., Hunter, D. J., Rimm, E. B., Willett, W. C., and Speizer, F. E. (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch. Intern. Med. 156, 2255-2260.
31. Hoffmann, D., and Hecht, S. S. (1990) Advances in tobacco carcinogenesis. In Handbook of Experimental Pharmacology (Cooper, C. S., and Grover, P. L., Eds.) pp 63-102, Springer-Verlag, Heidelberg.
32. Hecht, S. S., and Hoffmann, D. (1989) The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv. 8, 273-294.
33. Hecht, S. S., and Hoffmann, D. (1991) 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a nicotine-derived tobacco-specific nitrosamine, and cancer of the lung and pancreas in humans. In Origins of Human Cancer: A Comprehensive Review (Brugge, J., Curran, T., Harlow, E., and McCormick, F., Eds.) pp 745-755, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
34. Hoffmann, D., Djordjevic, M. V., Fan, J., Zang, E., Glynn, T., and Connolly, G. N. (1995) Five leading U.S. commercial brands of moist snuff in 1994 - assessment of carcinogenic N-nitrosamines. J. Natl. Cancer Inst. 87, 1862-1869.
35. Idris, A. M., Nair, J., Ohshima, H., Friesen, M., Brouet, I., Faustman, E. M., and Bartsch, H. (1991) Unusually high levels of carcinogenic tobacco-specific nitrosamines in Sudan snuff (toombak). Carcinogenesis 12, 1115-1118.
36. Magee, P. N. (1989) The experimental basis for the role of nitroso compounds in human cancer. Cancer Surv. 8, 207-239.
37. Preston-Martin, S., and Correa, P. (1989) Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv. 8, 459-473.
38. Magee, P. N. (1996) Nitrosamines and human cancer: introduction and overview. Eur. J. Cancer Prev. 5, 7-10.
39. Bartsch, H., and Spielhalder, B. (1996) Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur. J. Cancer Prev. 5, 11-18.
40. Hecht, S. S., Castonguay, A., Rivenson, A., Mu, B., and Hoffmann, D. (1983) Tobacco specific nitrosamines: carcinogenicity, metabolism, and possible role in human cancer. J. Environ. Sci. Health C1, 1-54.
41. Hecht, S. S. (1994) Metabolic activation and detoxification of tobacco-specific nitrosamines-a model for cancer prevention strategies. Drug Metab. Rev. 26, 373-390.
42. Hecht, S. S. (1996) Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen. CRC Crit. Rev. Toxicol. 26, 163-181.
43. Tricker, A. R. (1997) N-Nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur. J. Cancer Prev. 6, 226-268.
44. Connolly, G. N., Winn, D. M., Hecht, S. S., Henningfield, J. E., Walker, B., Jr., and Hoffmann, D. (1986) The reemergence of smokeless tobacco. New Engl. J. Med. 314, 1020-1027.
45. Shopland, D. (1997) U.S. consumption of chewing tobacco and snuff, 1982-1997. J. Natl. Cancer Inst. 84, 1573.
46. Hecht, S. S., Young, R., and Chen, C. B. (1980) Metabolism in the F344 rat of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco specific carcinogen. Cancer Res. 40, 4144-4150.
47. Castonguay, A., Tjälve, H., and Hecht, S. S. (1983) Tissue distribution of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, and its metabolites in F344 rats. Cancer Res, 43, 630-638.
48. Carmella, S. G., and Hecht, S. S. (1985) High-performance liquid Chromatographie analysis of metabolites of the nicotine derived nitrosamines, N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Anal. Biochem. 145, 239-244.
49. Chung, F.-L., Wang, M., and Hecht, S. S. (1985) Effects of dietary indoles and isothiocyanates on N-nitrosodimethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone α-hydroxylation and DNA methylation in rat liver. Carcinogenesis 6, 539-543.
50. Devereux, T. R., Andersen, M. W., and Belinsky, S. A. (1988) Factors regulating activation and DNA alkylation by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and nitrosodimethylamine in rat lung and isolated lung cells, and their relationship to carcinogenicity. Cancer Res. 48, 4215-4221.
51. Liu, L., Alaoui-Jamali, M. A., El Alami, N., and Castonguay, A. (1990) Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes. Cancer Res. 50, 1810-1816.
52. Alaoui-Jamali, M. A., Bélanger, P. M., Rossignol, G., and Castonguay, A. (1991) Metabolism, sister chromatid exchanges, and DNA single-strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their modulation by vitamin A in vitro. Cancer Res. 51, 3946-3950.
53. Alaoui-Jamali, M. A., Rossignol, G., and Castonguay, A. (1991) Protective effects of vitamin A against the genotoxicity of NNK, a nicotine-derived N-nitrosamine. Carcinogenesis 12, 379-384.
54. Castonguay, A., Pepin, P., and Briere, N. (1991) Modulation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone demethylation and denitrosation by rat liver microsomes. Cancer Lett. 59, 67-74.
55. Liu, L., and Castonguay, A. (1991) Inhibition of the metabolism and genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat hepatocytes by (+)-catechin. Carcinogenesis 12, 1203-1208.
56. Demkowicz-Dobrzanski, K., and Castonguay, A. (1992) Modulation by glutathione of DNA strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its aldehyde metabolites in rat hepatocytes. Carcinogenesis 13, 1447-1454.
57. Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Arch. Biochem. Biophys. 298, 279-286.
58. Guo, Z., Smith, T. J., Wang, E., Sadrieh, N., Ma, Q., Thomas, P. E., and Yang, C. S. (1992) Effects of phenethyl isothiocyanate, a Carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis 13, 2205-2210.
59. Guo, Z., Smith, T. J., Wang, E., Eklind, K. I., Chung, F.-L., and Yang, C. S. (1993) Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobioticmetabolizing enzymes in rats and mice. Carcinogenesis 14, 1167-1173.
60. Murphy, S. E., and Coletta, K. A. (1993) Two type of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells. Cancer Res. 53, 777-783.
61. Zhang, Z., Hamilton, S. M., Stewart, C., Strothier, A., and Teel, R. W. (1993) Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 13, 2341-2346.
62. Peterson, L. A., Ng, D. K., Stearns, R. A., and Hecht, S. S. (1994) Formation of NADP(H) analogues of tobacco specific nitrosamines in rat liver and pancreatic microsomes. Chem. Res. Toxicol. 7, 599-608.
63. Hamilton, S. M., and Teel, R. W. (1994) Effects of isothiocyanates on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene by hamster and rat liver microsomes. Anticancer Res. 14, 1089-1094.
64. Murphy, S. E., Spina, D. A., Nunes, M. G., and Pullo, D. A. (1995) Glucuronidation of 4-(hydroxymethyl)nitrosamino-1-(3-pyridyl)1-butanone, a metabolically activated form of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, by phenobarbital treated rats. Chem. Res. Toxicol. 8, 772-779.
65. El-Bayoumy, K., Prokopczyk, B., Peterson, L. A., Desai, D., Amin, S., Reddy, B. S., Hoffmann, D., and Wynder, E. (1996) Effects of dietary fat content on the metabolism of NNK and on DNA methylation induced by NNK. Nutr. Cancer 26, 1-10.
66. Murphy, S. E., Nunes, M. G., and Hatala, M. A. (1997) Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. Chem.-Biol. Interact. 103, 153-166.
67. Staretz, M. E., Koenig, L., and Hecht, S. S. (1997) Effects of long-term phenethyl isothiocyanate treatment on microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 18, 1715-1722.
68. Lamoureux, J., and Castonguay, A. (1997) Absence of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by flavin-containing monoxygenase (FMO). Carcinogenesis 18, 1979-1984.
69. Belinsky, S. A., White, C. M., Trushin, N., and Hecht, S. S. (1989) Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fisher rat. Carcinogenesis 10, 2269-2274.
70. Doerr-O'Rourke, K., Trushin, N., Hecht, S. S., and Stoner, G. D. (1991) Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Carcinogenesis 12, 1029-1034.
71. Guo, Z., Smith, T. J., Thomas, P. E., and Yang, C. S. (1991) Metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone as measured by DNA alkylation in vitro and its inhibition by isothiocyanates. Cancer Res. 51, 4798-4803.
72. Smith, T. J., Guo, Z., Hong, J.-Y., Ning, S. M., Thomas, P. E., and Yang, C. S. (1992) Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in microsomes of rat lung and nasal mucosa. Carcinogenesis 13, 1409-1414.
73. Ardies, C. M., Smith, T. J., Kim, S., and Yang, C. S. (1996) Induction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) activation in rat lung microsomes by chronic ethanol consumption and repeated running exercise. Cancer Lett. 103, 209-218.
74. Brittebo, E. B., Castonguay, A., Furuya, K., and Hecht, S. S. (1983) Metabolism of tobacco specific nitrosamines by cultured rat nasal mucosa. Cancer Res. 43, 4343-4348.
75. Hong, J.-Y., Smith, T., Lee, M.-J., Li, W., Ma, B.-L., Ning, S. M., Brady, J. F., and Thomas, P. E. (1991) Metabolism of carcinogenic nitrosamines by rat nasal mucosa and the effect of diallyl sulfide. Cancer Res. 51, 1509-1514.
76. Hong, J.-Y., Ding, X., Smith, T. J., Coon, M. J., and Yang, C. S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb. Carcinogenesis 13, 2141-2144.
77. Eriksson, C., Busk, L., and Brittebo, E. B. (1996) 3-Aminobenzamide: effects on cytochrome P-450-dependent metabolism of chemicals and on the toxicity of dichlobenil in the olfactory mucosa. Toxicol. Appl. Pharmacol. 138, 324-331.
78. Murphy, S. E., Heiblum, R., and Trushin, N. (1990) Comparative metabolism of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat oral tissue and esophagus. Cancer Res. 50, 4685-4691.
79. Murphy, S. E., and Heiblum, R. (1990) Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue. Carcinogenesis 11, 1663-1666.
80. Murphy, S. E., Heiblum, S., King, P. G., Bowman, D., Davis, W. J., and Stoner, G. D. (1991) Effect of phenethyl isothiocyanate on the metabolism of tobacco-specific nitrosamines by cultured rat oral tissue. Carcinogenesis 12, 957-961.
81. Schulze, J., Malone, A., and Richter, E. (1995) Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: sex-difference, inducibility and inhibition by phenethylisothiocyanate. Carcinogenesis 16, 1733-1740.
82. Tjälve, H., and Castonguay, A. (1983) The in vivo tissue disposition and in vitro target-tissue metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in Syrian golden hamsters. Carcinogenesis 4, 1259-1265.
83. Jorquera, R., Castonguay, A., and Schuller, H. M. (1992) Effects of pregnancy and ethanol treatment on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes. Drug Metab. Dispos, 20, 510-517.
84. Castonguay, A., and Rossignol, G. (1992) Modulation of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster liver microsomes to protein alkylating species. Toxicol. in Vitro 6, 397-404.
85. Jorquera, R., Castonguay, A., and Schuller, H. M. (1993) Effect of tobacco smoke condensate on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes. Drug Metab. Dispos. 21, 318-324.
86. Miller, C. H., Zhang, Z., Hamilton, S. M., and Teel, R. W. (1993) Effects of capsaicin on liver microsomal metabolism of the tobacco-specific nitrosamine NNK. Cancer Lett. 75, 45-52.
87. Hamilton, S. M., Zhang, Z., and Teel, R. W. (1994) Effects of isothiocyanate alkyl chain-length on hamster liver cytochrome P-450 activity. Cancer Lett. 82, 217-224.
88. Miller, C. H., Hamilton, S. M., and Teel, R. W. (1994) Effects of compounds of plant origin on the mutagenicity and metabolism of the tobacco-specific nitrosamine NNK. Phytother, Res. 8, 342-347.
89. Miller, C., Castonguay, A., and Teel, R. W. (1996) Modulation of the mutagenicity and metabolism of the tobacco specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by phenolic compounds. Mutat. Res. 368, 221-233.
90. Zhang, Z., Huynh, H., and Teel, R. W. (1997) Effects of orally administered capsaicin, the principal component of capsicum fruits, on the in vitro metabolism of the tobacco-specific nitrosamine NNK in hamster lung and liver microsomes. Anticancer Res. 17, 1093-1098.
91. Rossignol, G., Alaoui-Jamali, M. A., Castonguay, A., and Schuller, H. M. (1989) Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster. Cancer Res. 49, 5671-5676.
92. Charest, M., Rossignol, G., and Castonguay, A. (1989) In vitro and in vivo modulation of the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in hamster lung tissues. Ckem.-Biol. Interact. 71, 265-278.
93. Castonguay, A., Allaire, L., Charest, M., Rossignol, G., and Beutet, M. (1989) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone by hamster respiratory tissues cultured with ellagic acid. Cancer Lett. 46, 93-105.
94. Alaoui-Jamali, M. A., Massey, T. E., Douglas, A., Rossignol, G., and Castonguay, A. (1990) In vitro metabolism of 4-(methylnit- rosamino)-1-(3-pyridyl)-1-butanone by lung cells isolated from Syrian golden hamster. Cancer Lett. 52, 49-55.
95. Schuller, H. M., Castonguay, A., Orloff, M., and Rossignol, G. (1991) Modulation of the uptake and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by nicotine in hamster lung. Cancer Res. 51, 2009-2014.
96. Schulze, J., Schlager, W., Wunsch, R., and Richter, E. (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by hamster, mouse and rat intestine: relevance of species differences. Carcinogenesis 17, 1093-1099.
97. Castonguay, A., Tjälve, H., Trushin, N., and Hecht, S. S. (1984) Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57B1 mice. J. Nati. Cancer Inst. 72, 1117-1126.
98. Morse, M. A., LaGreca, S. D., Amin, S. G., and Chung, F.-L. (1990) Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosammo)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice. Cancer Res. 50, 2613-2617.
99. Peterson, L. A., Mathew, R., and Hecht, S. S. (1991) Quantitation of metabolic α-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 51, 5495-5500.
100. Lin, J.-M., Desai, D. H., Morse, M. A., Amin, S., and Hecht, S. S. (1992) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone pulmonary metabolism and tumorigenicity in mice by analogues of the investigational chemotherapeutic drug 4-ipomeanol. Chem. Res. Toxicol. 5, 674-679.
101. Hong, J.-Y., Wang, Z. Y., Smith, T. J., Zhou, S., Shi, S., Pan, J., and Yang, C. S. (1992) Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 13, 901-904.
102. Smith, T. J., Guo, Z., Li, C., Ning, S. M., Thomas, P. E., and Yang, C. S. (1993) Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate. Cancer Res. 53, 3276-3282.
103. Morse, M. A., Kresty, L. A., and Toburen, A. L. (1995) Inhibition of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by dietary benzaldehydes. Cancer Lett. 97, 255-261.
104. Desai, D., Nunes, M., Chang, L., Lin, J.-M., Jiao, D., and Amin, S. (1995) Ipomeanol analogues as chemopreventive agents: effect on the in vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett. 97, 155-162.
105. Morse, M. A., and Toburen, A. L. (1996) Inhibition of metabolic activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by limonene. Cancer Lett. 104, 211-217.
106. Castonguay, A., Lin, D., Stoner, G. D., Radok, P., Furuya, K., Hecht, S. S., Schut, H. A. J., and Klaunig, J. E. (1983) Comparative carcinogenicity in A/J mice and metabolism by cultured mouse peripheral lung of N′-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res. 43, 1223-1229.
107. 6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res. 49, 2894-2897.
108. Smith, T. J., Guo, Z., Thomas, P. E., Chung, F.-L., Morse, M. A., Eklind, K. and Yang, C. S. (1990) Metabolism of 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res. 50, 6817-6822.
109. Pepin, P., Bouchard, L., Nicole, P., and Castonguay, A. (1992) Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis 13, 341-348.
110. Bouchard, L., and Castonguay, A. (1993) Inhibitory effects of nonsteroidal antiinflammatory drugs (NSAIDs) on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mouse lung expiants. Drug Metab. Dispos. 21, 293-298.
111. Guo, Z., Wang, M., Tian, G., Burger, J., Gochfeld, M., and Yang, C. S. (1993) Age- and gender-related variations in the activities of drug-metabolizing and antioxidant enzymes in the white-footed mouse (Peromyscus leucopus). Growth, Dev., Aging 57, 85-100.
112. Shi, S. T., Wang, Z.-Y., Smith, T. J., Hong, J.-Y., Chen, W.-F., Ho, C.-T., and Yang, C. S. (1994) Effects of green tea and black tea on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Res. 54, 4641-4647.
113. Jiao, D., Smith, T. J., Kim, S., Yang, C. S., Desai, D., Amin, S., and Chung, F. L. (1996) The essential role of the functional group in alkyl isothiocyanates for inhibition of tobacco-nitrosamine-induced lung tumorigenesis. Carcinogenesis 17, 755-759.
114. Pepin, P., Rossignol, G., and Castonguay, A. (1990) Inhibition of NNK-induced lung tumorigenesis in A/J mice by ellagic acid and butylated hydroxyanisole. Cancer J. 3, 266-273.
115. Smith, T., Liao, A., Liu, Y., Jones, A., Anderson, L., and Yang, C. (1997) Enzymes involved in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in patas monkey lung and liver microsomes. Carcinogenesis 18, 1577-1584.
116. Castonguay, A., Stoner, G. D., Schut, H. A. J., and Hecht, S. S. (1983) Metabolism of tobacco-specific N-nitros amines by cultured human tissues. Proc. Natl. Acad. Sci. U.S.A. 80, 6694-6697.
117. Smith, T. J., Quo, Z. Y., Gonzalez, F. J., Guengerich, F. P., Stoner, G. D., and Yang, C. S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res. 52, 1757-1763.
118. Staretz, M. E., Murphy, S, E., Nunes, M. G., Koehl, W., Amin, S., Koenig, L., Guengerich, F. P., and Hecht, S. S. (1997) Comparative metabolism of the tobacco smoke carcinogens benzo[a]pyrene, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N′-nitrosonornicotine in human hepatic microsomes. Drug Metab. Dispos. 25, 154-162.
119. Smith, T. J., Stoner, G. D., and Yang, C. S. (1995) Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Res. 55, 5566-5573.
120. Liu, Y., Sundqvist, K., Belinsky, S. A., Castonguay, A., Tjalve, H., and Grafstrom, R. C. (1993) Metabolism and macromolecular interaction of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in cultured expiants and epithelial cells of human buccal mucosa. Carcinogenesis 14, 2383-2388.
121. Collazo, N. R., and Sultatos, L. G. (1995) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human placental microsomes. Biochem. Pharmacol. 50, 1933-1941.
122. Atawodi, S. E., and Richter, E. (1996) Bacterial reduction of N-oxides of tobacco-specific nitrosamines (TSNA). Human Exp. Toxicol. 15, 329-334.
123. Anderson, K. E., Hammons, G. J., Kadlubar, F. F., Potter, J. D., Kaderlik, K. R., Ilett, K. F., Minchin, R. F., Teitel, C. H., Chou, H.-C., Martin, M. V., Guengerich, F. P., Barone, G. W., Lang, N. P., and Peterson, L. A. (1997) Metabolie activation of aromatic amines by human pancreas. Carcinogenesis 18, 1085-1092.
124. Hecht, S. S., Spratt, T. E., and Trushin, N. (1997) Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 18, 1851-1854.
125. Prokopcyzk, B., Trushin, N., Cox, J. E., El-Bayoumy, K., Hoffmann, D., Schoenberg, M. H., and Wynder, E. L. (1997) Identification of the tobacco carcinogen NNK in the pancreatic juice of smokers and its metabolism by human pancreatic microsomes. Proc. Am. Assoc. Cancer Res. 38, 340.
126. Hecht, S. S., Jordan, K. G., Choi, C.-I., and Trushin, N. (1990) Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesis 11, 1017-1020.
127. Rivenson, A., Hoffmann, D., Prokopczyk, B., Amin, S., and Hecht, S. S. (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48, 6912-6917.
128. Patten, C. J., Smith, T. J., Murphy, S. E., Wang, M.-H., Lee, J., Tynes, R. E., Koch, P., and Yang, C. S. (1996) Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes. Arch. Biochem. Biophys. 333, 127-138.
129. Lee, V. M., Keefer, L. K., and Archer, M. C. (1996) An evaluation of the roles of metabolic denitrosation and alpha-hydroxylation in the hepatotoxicity of N-nitrosodimethylamine. Chem. Res. Toxicol. 9, 1319-1324.
130. Guo, Z., Smith, T. J., Ishizaki, H., and Yang, C. S. (1991) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system. Carcinogenesis 12, 2277-2282.
131. Lacroix, D., Desrochers, M., Castonguay, A., and Anderson, A. (1993) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Carcinogenesis 14, 1639-1642.
132. Crespi, C. L., Penman, B. W., Gelboin, H. V., and Gonzalez, F. (1991) A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonet is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 12, 1197-1201.
133. Islam, S. A., Wolf, C. R., Lennard, M. S., and Sternberg, M. J. (1991) A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation. Carcinogenesis 12, 2211-2219.
134. Yamazaki, H., Inui, Y., Yun, C.-H., Guengerich, F. P., and Shimada, T. (1992) Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 13, 1789-1794.
135. Penman, B. W., Reece, J., Smith, T., Yang, C. S., Gelboin, H. V., Gonzales, F. J., and Crespi, C. L. (1993) Characterization of a human cell line expressing high levels of cDNA-derived CYP2D5. Pharmacogenetics 3, 28-39.
136. Tiano, H. F., Hosokawa, M., Chulada, P. C., Smith, P. B., Wang, R.-L., Gonzalez, F. J., Crespi, C. L., and Langenbach, R. (1993) Retroviral mediated expression of human cytochrome P450 2A6 in C3H/10T1/2 cells confers transformability by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 14, 1421-1427.
137. Nesnow, S., Beck, S., Rosenblum, S., Lasley, J., Tiano, H. F., Hosokawa, M., Crespi, C. L., and Langenbach, R. (1994) N-Nitrosodiethylamine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced morphological transformation of C3H/10T1/ 2CL8 cells expressing human cytochrome P450 2A6. Mutat. Res. 324, 93-102.
138. Smith, T. J., Guo, Z., Guengerich, F. P., and Yang, C. S. (1996) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis 17, 809-813.
139. Duperron, C., and Castonguay, A. (1997) Chemoprevention efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis 18, 1001-1006.
140. Code, E., Crespi, C., Penman, B., Gonzalez, F., Chang, T., and Waxman, D. (1997) Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab. Dispos. 25, 985-993.
141. Maser, E., Richter, E., and Friebertshauser, J. (1996) The identification of 11β-hydroxysteriod dehydrogenese as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Eur. J. Biochem. 238, 484-489.
142. Maser, E. (1997) Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer? TIPS 18, 270-275.
143. Reefer, L. K., Anjo, T., Wade, D., Wang, T., and Yang, C. S. (1987) Concurrent generation of methylamine and nitrite during denitrosation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res. 47, 447-452.
144. Wade, D., Yang, C. S., Metral, C. J., Roman, J. M., Hrabie, J. A., Riggs, C. W., Anjo, T., Keefer, L. K., and Mico, B. A. (1987) Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes. Cancer Res. 47, 3373-3377.
145. Adams, J. D., LaVoie, E. J., and Hoffmann, D. (1985) On the pharmacokinetics of tobacco-specific N-nitrosamines in Fisher rats. Carcinogenesis 6, 509-511.
146. Hecht, S. S., Trushin, N., Castonguay, A., and Rivenson, A. (1986) Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46, 498-502.
147. LaVoie, E. J., Stern, S. L., Choi, C.-I., Reinhardt, J., and Adams, J. D. (1987) Transfer of the tobacco-specific carcinogens N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene into the milk of lacating rats. Carcinogenesis 8, 433-437.
148. Prokopczyk, G., Adams, J., LaVoie, E., and Hoffmann, D. (1987) Effect of snuff and nicotine on DNA methylalion by 4-(methylnitrosamino)-1-3pyridyl-1-butanone. Carcinogenesis 8, 1395-1397.
149. Morse, M. A., Eklind, K. I., Toussaint, M., Amin, S. G., and Chung, F.-L. (1990) Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis 11, 1819-1823.
150. Schulze, J., Richter, E., Binder, U., and Zwickenpflug, W. (1992) Biliary excretion of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the rat. Carcinogenesis 13, 1961-1965.
151. Desai, D., Kagan, S. S., Amin, S., Carmella, S. G., and Hecht, S. S. (1993) Identification of 4-(methylnitrosamino)-1-[3-(6-hydroxypyridyl)]-1-butanone as a urinary metabolite of 4-(methylnitrosainino)-1-(3-pyridyl)-1-butanone in the rat. Chem. Res. Toxicol. 6, 794-799.
152. Atawodi, S. E., Michelsen, K., and Richter, E. (1994) Metabolism of a glucuronide conjugate of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Arch. Toxicol. 69, 14-17.
153. Richter, E., and Tricker, A. R. (1994) Nicotine inhibits the metabolic activation of the tobacco-specific nitroamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis 15, 1061-1064.
154. Staretz, M. E., and Hecht, S. S. (1995) Effects of phenethyl isothiocyanate on the tissue distribution of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites in F344 rats. Cancer Res. 55, 5580-5588.
155. Hecht, S. S., Trushin, N., Rigotty, J., Carmella, S. G., Borukhova, A., Akerkar, S. A., Desai, D., Amin, S., and Rivenson, A. (1996) Inhibitory effects of 6-phenylhexyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation and lung turnorigenesis in rats. Carcinogenesis 17, 2061-2067.
156. Hecht, S. S., Trushin, N., Rigotty, J., Carmella, S. G., Borukhova, A., Akerkar, S. A., and Rivenson, A. (1996) Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol., Biomarkers Prev. 5, 645-652.
157. Hoffmann, D., Castonguay, A., Rivenson, A., and Hecht, S. S. (1981) Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine in Syrian golden hamsters. Cancer Res. 41, 2386-2393.
158. Adams, J. D., LaVoie, E. J., O'Mara-Adams, K. J., Hoffmann, D., Carey, K. D., and Marshall, M. V. (1985) Pharmacokinetics of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett. 28, 195-201.
159. Castonguay, A., Tjälve, H., Trushin, N., d'Argy, R., and Sperber, G. (1985) Metabolism and tissue distribution of tobacco-specific N-nitrosamines in the marmoset monkey (Callithrix jacchus). Carcinogenesis 6, 1543-1550.
160. Hecht, S. S., Trushin, N., Reid-Quinn, C. A., Burak, E. S., Jones, A. B., Southers, J. L., Gombar, C. T., Carmella, S. G., Anderson, L. M., and Rice, J. M. (1993) Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis 14, 229-236.
161. Idris, A. M., Nair, J., Friesen, M., Ohshima, H., Brouet, I., Faustman, E. M., and Bartsch, H. (1992) Carcinogenic tobaccospecific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis 13, 1001-1005.
162. Carmella, S. G., Akerkar, S., and Hecht, S. S. (1993) Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3pyridyD-1-butanone in smokers' urine. Cancer Res. 53, 721-724.
163. Hecht, S. S., Carmella, S. G., Murphy, S. E., Akerkar, S., Brunnemann, K. D., and Hoffmann, D. (1993) A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. New Engl. J. Med. 329, 1543-1546.
164. Murphy, S. E., Carmella, S. G., Idris, A. M., and Hoffmann, D. (1994) Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol., Biomarkers Prev. 3, 423-428.
165. Hecht, S. S., Chung, F.-L., Richie, J. P., Jr., Akerkar, S. A., Borukhova, A., Skowronski, L., and Carmella, S. G. (1995) Effects of watercress consumption on metabolism of a tobaccospecific lung carcinogen in smokers. Cancer Epidemiol., Biomarkers Prev. 4, 877-884.
166. Carmella, S. G., Akerkar, S., Richie, J. P., Jr., and Hecht, S. S. (1995) Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol., Biomarkers Prev. 4, 635-642.
167. Kresty, L. A., Carmella, S. G., Borukhova, A., Akerkar, S. A., Gopalakrishnan, R., Harris, R. E., Stoner, G. D., and Hecht, S. S. (1996) Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users; relationship of urinary biomarkers and oral leukoplakia. Cancer Epidemiol., Biomarkers Prev. 5, 521-525.
168. Carmella, S. G., Borukhova, A., Akerkar, S. A., and Hecht, S. S. (1997) Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobaccospecific lung carcinogen. Cancer Epidemiol., Biomarkers Prev. 6, 113-120.
169. Taioli, E., Garbers, S., Bradlow, H. L., Carmella, S. G., Akekar, S., and Hecht, S. S. (1997) Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers. Cancer Epidemiol., Biomarkers Prev. 6, 517-522.
170. Meger, M., Meger-Kossien, I., Dietrich, M., Tricker, A. R., Scherer, G., and Adlkofer, F. (1996) Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers. Eur. J. Cancer Prev. 5, 121-124.
171. Hecht, S. S., Lin, D., and Chen, C. B. (1981) Comprehensive analysis of urinary metabolites of N′-nitrosonornicotine. Carcinogenesis 2, 833-838.
172. Hecht, S. S., and Trushin, N. (1997) Stereoselectivity in the metabolic formation of 4-hydroxy-4-(3-pyridyl-butanoic acid (HPBA) from nicotine, N′-nitrosonornicotine (NNN), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rats. Proc. Am. Assoc. Cancer Res. 38, 463.
173. Fay, L. B., Leaf, C. D., Gremaud, E., Aeschlimann, J.-M., Steen, C., Shuker, D. E. G., and Turesky, R. J. (1997) Urinary excretion of 3-methyladenine after consumption of fish containing high levels of dimethylamine. Carcinogenesis 18, 1039-1044.
174. Stillwell, W. G., Glogowski, J., Xu, H.-X., Wishnok, J. S., Zavala, D., Montes, G., Correa, P., and Tannenbaum, S. R. (1991) Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine, and 7-methylguanine in a Colombian population at high risk for stomach cancer. Cancer Res. 51, 190-194.
175. Prevost, V., and Shuker, D. E. G. (1996) Cigarette smoking and urinary 3-alkyladenine excretion in man. Chem. Res. Toxicol. 9, 439-444.
176. Kopplin, A., Eberle-Adamkiewicz, G., Glüsenkamp, K.-H., Nehls, P., and Kirstein, U. (1995) Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke. Carcinogenesis 16, 2637-2641.
177. 6-methyldeoxyguanosine in DNA methylated by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone using a biotin-avidin enzyme-linked immunosorbent assay. Carcinogenesis 6, 989-993.
178. Castonguay, A., Foiles, P. G., Trushin, N., and Hecht, S, S. (1985) Study of DNA methylation by tobacco-specific N-nitrosamines. Environ. Health Perspect. 62, 197-202.
179. Hecht, S. S., Lin, D., Chuang, J., and Castonguay, A. (1986) Reactions with deoxyguanosine of 4-(carbethoxynitroeamino)-1-(3-pyridyl)-1-butanone, a model compound for α-hydroxylation of tobacco specific nitrosamines. J. Am. Chem. Soc. 108, 1292-1295.
180. Hecht, S. S., Spratt, T. E., and Trushin, N. (1988) Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyD-1-butanone and N′-nitrosonornicotine. Carcinogenesis 9, 161-165.
181. 2-(pyridyloxobutyl)deoxyguanosine adducts in DNA of tissues exposed to tritium-labeled 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Chem. Res. Toxicol. 2, 169-173.
182. Peterson, L. A., Mathew, R., Murphy, S. E., Trushin, N., and Hecht, S. S. (1991) In vivo and in vitro persistence of pyridyloxobutyl DNA adducts from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 12, 2069-2072.
183. Foiles, P. G., Peterson, L. A., Miglietta, L. M., and Ronai, Z. (1992) Analysis of mutagenic activity and ability to induce replication of polyoma DNA sequences by different model compounds of the carcinogenic tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Mutat. Res. 279, 91-101.
184. 6-methylguanine. Cancer Res. 53, 2780-2785.
185. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 9, 949-953.
186. 6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 10, 562-567.
187. 6-methylguanine built into a unique site in a viral genome. Proc. Natl. Acad. Sci. U.S.A. 81, 6271-6275.
188. Hecht, S. S., Lin, D., and Castonguay, A. (1983) Effects of α-deuterium substitution on the mutagenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis 4, 305-310.
189. Ronai, Z., Gradia, S., Peterson, L. A., and Hecht, S. S. (1993) G to A transitions and G to T transversions in codon 12 of the K-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. Carcinogenesis 14, 2419-2422.
190. Singer, B., and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens, pp 45-96, Plenum Press, New York.
191. Hecht, S. S., and Chen, C. B. (1979) Hydrolysis of model compounds for α-hydroxylation of the carcinogens, N-nitrosopyrrolidine and N′-nitrosonornicotine. J. Org. Chem. 44, 1563-1566.
192. Hecht, S. S., and Lin, D. (1986) Comparative mutagenicity of 4-(carbethoxynitrosamino)-4-(3-pyridyl)butanal and 4-(carbethoxynitrosamino)-1-(3-pyridyl)-1-butanone, model compounds for α-hydroxylation of N′-nitrosonornicotine. Carcinogenesis 7, 611-614.
193. Peterson, L. A., Carmella, S. G., and Hecht, S. S. (1990) Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 11, 1329-1333.
194. Spratt, T. E., Peterson, L. A., Confer, W. L., and Hecht, S. S. (1990) Solvolysis of model compounds for α-hydroxylation of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: evidence for a cyclic oxonium ion intermediate in the alkylation of nucleophiles. Chem. Res. Toxicol. 3, 350-356.
195. 6-Methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51, 5557-5564.
196. Hecht, S. S., and Trushin, N. (1988) DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis 9, 1665-1668.
197. Murphy, S. E., Palomino, A., Hecht, S. S., and Hoffmann, D. (1990) Dose-response study of DNA and hemoglobin adduct formation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 50, 5446-5452.
198. Foiles, P. G., Akerkar, S. A., Carmella, S. G., Kagan, M., Stoner, G. D., Resau, J. H., and Hecht, S. S. (1991) Mass spectrometric analysis of tobacco-specific nitrosamine-DNA adducts in smokers and nonsmokers. Chem. Res. Toxicol. 4, 364-368.
199. Trushin, N., Rivenson, A., and Hecht, S. S. (1994) Evidence supporting the role of DNA pyridyloxobutylation in rat nasal carcinogenesis by tobacco specific nitrosamines. Cancer Res. 54, 1205-1211.
200. Staretz, M. E., Foiles, P. G., Miglietta, L. M., and Hecht, S. S. (1997) Evidence for an important role of DNA pyridyloxobutylation in rat lung Carcinogenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone; effects of dose and phenethyl isothiocyanate. Cancer Res. 57, 259-266.
201. 2-tetrahydropyranyl adducts. Chem. Res. Toxicol. 8, 607-616.
202. 2-tetrahydropyranyl adducts in the reactions of α-acetoxy-N-nitrosopyrrolidine and α-acetoxy-N-nitrosopiperidine with DNA. Chem. Res. Toxicol. 8, 617-624.
203. Latif, F., Moschel, R. C., Hemminki, K., and Dipple, A. (1988) Styrene oxide as a stereochemical probe for the mechanism of aralkylation at different sites on guanosine. Chem. Res. Toxicol. 1, 364-369.
204. 6-methylguanine. Cancer Res. 53, 2780-2785.
205. Castonguay, A., Tharp, R., and Hecht, S. S. (1984) Kinetics of DNA methylation by the tobacco specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. In N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer (O'Neill, I. K., Von Borstel, R. C., Miller, C. T., Long, J., and Bartsch, H., Eds.) pp 805-810, International Agency for Research on Cancer, Lyon, France.
206. Belinsky, S. A., White, C. M., Boucheron, J. A., Richardson, F. C., Swenberg, J. A., and Anderson, M. (1986) Accumulation and persistence of DNA adducts in respiratory tissue of rats following multiple administrations of the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanor)e. Cancer Res. 46, 1280-1284.
207. Belinsky, S. A., White, C. M., Devereux, T. R., Swenberg, J. A., and Anderson, M. W. (1987) Cell-selective alkylation of DNA in rat lung following low dose exposure to the tobacco specific carcinogen 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 47, 1143-1148.
208. Belinsky, S. A., Walker, V. E., Maronpot, R. R., Swenberg, J. A., and Anderson, M. W. (1987) Molecular dosimetry of DNA adduct formation and cell toxicity in rat nasal mucosa following exposure to the tobacco specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone and their relationship to induction of neoplasia. Cancer Res. 47, 6058-6065.
209. 6-methylguanine in rat pulmonary cells. Carcinogenesis 9, 2053-2058.
210. 6-methylguanine-DNA-transmethylase activity and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA methylation and tumprigenicity in F344 rats. Carcinogenesis 9, 1891-1895.
211. Morse, M. A., Wang, C.-X., Stoner, G. D., Mandal, S., Conran, P. B., Amin, S. G., Hecht, S. S., and Chung, F.-L. (1989) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res. 49, 549-553.
212. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 50, 3772-3780.
213. Chung, F.-L., and Xu, Y. (1992) Increased 8-hydroxydeoxyguanosine levels in lung DNA of A/J mice and F344 rats treated with the tobacco-specific nitrosamine 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone. Carcinogenesis 13, 1269-1272.
214. Liu, L., Castonguay, A., and Gerson, S. L. (1992) Lack of correlation between DNA methylation and hepatocarcinogenesis in rats and hamsters treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 13, 2137-2140.
215. Bianchini, F., and Wild, C. P. (1994) Comparison of 7medG formation in white blood cells, liver and target organs in rats treated with methylating carcinogens. Carcinogenesis 15, 1137-1141.
216. 6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 15, 2023-2029.
217. 6-methylguanine in bone marrow and not in the spleen. Carcinogenesis 17, 2183-2191.
218. Prokopczyk, B., Cox, J. E., Upadhyaya, P., Amin, S., Desai, D., Hoffmann, D., and El-Bayoumy, K. (1996) Effects of dietary 1,4-phenylenebis(methylene)selenocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation in lung and liver of A/J mice and F344 rats. Carcinogenesis 17, 749-753.
219. Belinsky, S. A., Devereux, T. R., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. (1989) The relationship between the formation of promutagenic adducts and the activation of the K-ras proto-oncogene in lung tumors from A/J mice treated with nitrosamines. Cancer Res. 49, 5305-5311.
220. Hecht, S. S., Jordan, K. G., Choi, C.-L, and Trushin, N. (1990) Effects of deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice. Carcinogenesia 11, 1017-1020.
221. Devereux, T. R., Anderson, M. W., and Belinsky, S. A. (1991) Role of ras protooncogene activation in the formation of spontaneous and nitrosamine-induced lung tumors in the resistant C3H mouse. Carcinogenesis 12, 299-303.
222. Morse, M. A., Eklind, K. I., Hecht, S. S., Jordan, K. G., Choi, C.-I., Desai, D. H., Amin, S. G., and Chung, F.-L. (1991) Structure-activity relationships for inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone lung tumorigenesis by arylalkyl isothiocyanates in A/J mice. Cancer Res. 51, 1846-1850.
223. Xu, Y., Ho, C. T., Amin, S. G., Han, C., and Chung, F. L. (1992) Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 52, 3875-3879.
224. Belinsky, S. A., Devereux, T. R., Foley, J. F., Maronpot, R. R., and Anderson, M. W. (1992) Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methymitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse. Cancer Res. 52, 3164-3173.
225. 6-methylguanine DNA adduct levels and K-ras activation in lung tumors from resistant and susceptible mouse strains. Mol. Carcinog. 8, 177-185.
226. Hoffmann, D., Rivenson, A., Amin, S., and Hecht, S. S. (1984) Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J. Cancer Res. Clin. Oncol. 108, 81-86.
227. Hecht, S. S., Lin, D., Castonguay, A., and Rivenson, A. (1987) Effects of α-deuterium substitution on the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Carcinogenesis 8, 291-294.
228. Hecht, S. S., Morse, M. A., Amin, S., Stoner, G. D., Jordan, K. G., Choi, C.-I., and Chung, F.-L. (1989) Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis 10, 1901-1904.
229. 32-postlabeling assay. Carcinogenesis 14, 545-550.
230. 32P-postlabeling assay of N7 methyldeoxyguanosine. Cancer Res. 50, 6580-6584.
231. 32P-postlabeling analysis of 7-methylguanine in human bronchial and lymphocyte DNA. Carcinogenesis 14, 151-154.
232. Kato, S., Bowman, E., Harrington, A. M., Blomeke, B., and Shields, P. G. (1995) Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo. J. Natl. Cancer Inst. 87, 902-907.
233. Blomeke, B., Greenblatt, M. J., Doan, V. D., Bowman, E. D., Murphy, S. E., Chen, C. C., Kato, S., and Shields, P. G. (1996) Distribution of 7-alkyl-2′-deoxyguanosine adduct levels in human lung. Carcinogenesis 17, 741-748.
234. Petruzzelli, S., Tavanti, L. M., Celi, A., and Giuntini, C. (1996) Detection of N7-methyldeoxyguanosine adducts in human pulmonary alveolar cells. Am. J. Respir. Cell Moi Biol. 15, 216-223.
235. Alaoui-Jamali, M. A., Gagnon, R., El Alami, N., and Castonguay, A. (1990) Cytoloxicity, sister-chromatid exchanges and DNA single-strand breaks induced by 4-oxo-4-(3-pyridyl)butanal, a metabolite of a tobacco-specific N-nitrosamine. Mutat. Res. 240, 25-33.
236. Demkowicz-Dobrzanski, K., and Castonguay, A. (1991) Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes. Carcinogenesis 12, 2135-2140.
237. Pool-Zobel, B. L., Klein, R. G., Liegibel, U. M., Kuchenmeister, F., Weber, S., and Schmezer, P. (1992) Systemic genotoxic effects of tobacco-related nitrosamines following oral and inhalational administration to Sprague-Dawley rats. Clin. Invest. 70, 299-306.
238. Demkowicz-Dobrzanski, K., and Castonguay, A. (1991) Comparison of DNA alkali-labile sites induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-oxo-4-(3-pyridyl)butanal in rat hepatocytes. Carcinogenesis 12, 2135-2140.
239. Weitberg, A. B., and Corvese, D. (1993) Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin. Genet. 43, 88-89.
240. Jorquera, R., Castonguay, A., and Schuller, H. M. (1993) Effects of age and ethanol on DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or N-nitrosodimethylamine in hamster and rat liver. Cancer Lett. 74, 175-181.
241. Becher, R., Lag, M., Schwarze, P. E., Brunborg, G., Soderlund, E. J., and Holme, J. (1993) Chemically induced DNA damage in isolated rabbit lung cells. Mutat. Res. 285, 303-311.
242. Joquera, R., Castonguay, A., and Schuller, H. M. (1994) DNA single-strand breaks and toxicity induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone or N-nitrosoimethylamme in hamster and rat liver. Carcinogenesis 15, 389-394.
243. Sipowicz, M. A., Amin, S., Desai, D., Kasprzak, K. S., and Anderson, L. M. (1997) Oxidative DNA damage in tissues of pregnant female mice and fetuses caused by tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett. 117, 87-91.
244. Weitberg, A. B., and Corvese, D. (1997) Effect of vitamin E and beta-carotene on DNA strand breakage by tobacco-specific nitrosamines and stimulated human phagocytes. J. Exp. clin. Cancer Res. 16, 11-14.
245. Ehrenberg, L., and Osterman-Golkar, S. (1980) Alkylation of macromolecules for detecting mutagenic agents. Teratog., Carcinog., Mutagen. 1, 105-127.
246. Skipper, P. L., and Tannenbaum, S. R. (1990) Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11, 507-518.
247. Carmella, S. G., and Hecht, S. S. (1987) Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Cancer Res. 47, 2626-2630.
248. Carmella, S. G., Kagan, S. S., Spratt, T. E., and Hecht, S. S. (1990) Evaluation of cysteine adduct formation in rat hemoglobin by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and related compounds. Cancer Res. 50, 5453-5459.
249. Carmella, S. G., Kagan, S. S., and Hecht, S. S. (1992) Evidence that a hemoglobin adduct of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a 4-(3-pyridyl)-4-oxobutyl carboxylic acid ester. Chem. Res. Toxicol. 5, 76-80.
250. Carmella, S. G., Kagan, S. S., Kagan, M., Foiles, P. G., Palladino, G., Quart, A. M., Quart, E., and Hecht, S. S. (1990) Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res, 50, 5438-5445.
251. Richter, E., Schäffler, G., Malone, A., and Schulze, J. (1992) Tobacco-specific nitrosamines - metabolism and biological monitoring of exposure to tobacco products. Clin. Invest. 70, 290-294.
252. Falter, B., Kutzer, C., and Richter, E. (1994) Biomonitoring of hemoglobin adducts: aromatic amines and tobacco-specific nitrosamines. Clin. Invest. 72, 364-371.
253. Kutzer, G., Branner, B., Zwickenpflug, W., and Richter, E. (1997) Simultaneous solid-phase extration and gas chromatographicmass spectrometric determination of hemoglobin adducts from tobacco-specific nitrosamines and aromatic amines. J. Chromatogr. Sci. 35, 1-7.
254. Melikian, A. A., Sun, P., Pierpont, C., Coleman, S., and Hecht, S. S. (1997) Gas chromatography-mass spectrometric determination of benzo[a]pyrene and chrysene diol epoxide globin adducts in humans. Cancer Epidemiol., Biomarkers Prev. 6, 833-839.
255. Chen, B., Liu, L., Castonguay, A., Maronpot, R. R., Anderson, M. W., and You, M. (1993) Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis 14, 1603-1608.
256. Matzinger, S. A., Gunning, W. T., You, M., and Castonguay, A. (1994) K-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. Mol. Carcinog. 11, 42-48.
257. 1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. Carcinogenesis 16, 2487-2492.
258. Kawano, R., Takeshima, Y., and Inai, K. (1996) Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. Jpn. J. Cancer Res. 87, 44-50.
259. Oreffo, V. I. C., Lin, H.-W., Gumerlock, P. H., Kraegel, S. A., and Witschi, H. (1992) Mutational analysis of a dominant oncogene (c - K-ras-2) and a tumor suppressor gene (p53) in hamster lung tumorigenesis. Mol. Carcinog, 6, 199-202.
260. Oreffo, V. I. C., Lin, H.-W., Padmanabhan, R., and Witschi, H. (1993) K-ras and p53 point mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced hamster lung tumors. Carcinogenesis 14, 451-455.
261. Jiao, J., Zielenska, M., Anderson, M. W., and Glickman, B. W. (1991) Mutational specificities of environmental carcinogens in the lacI gene of Escherichia coli: IV. The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 12, 221-224.
262. Jiao, J., Guttenplan, J. B., Glickman, B. W., Anderson, M. W., Xin, L. Y., and Zielenska, M. (1993) Mutational specificities of environmental carcinogens in the lacl gene of Escherichia coli VII: the host-mediated assay and its comparison with in vitro mutagenesis induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Mol. Carcinog. 8, 127-131.
263. Tiano, H. F., Wang, R.-L., Hosokawa, M., Crespi, C., Tindall, K. R., and Langenbach, R. (1994) Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specifity in the gpt gene of AS52 cells. Carcinogenesis 15, 2859-2866.
264. Belinsky, S. A., Devereux, T. R., White, C. M., Foley, J. F., Maronpot, R. R., and Anderson, M. W. (1991) Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine. Exp. Lung Res. 17, 263-278.
265. Westra, W. H., Baas, I. O., Hruban, R. H., Askin, F. B., Wilson, K., Offerhaus, G. J. A., and Slebos, R. J. C. (1996) K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res. 56, 2224-2228.
266. Mills, X. E., Fishman, C. L., Rom, W. N., Dubin, N., and Jacobson, D. R. (1995) Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res. 55, 1444-1447.
267. Rodenhuis, S., and Slebos, R. J. C. (1992) Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 52 (Supple.), 2665s-2669s.
268. Westra, W. H., Slebos, R. J. C., Offerhaus, C. J. A., Goodman, S. N., Evers, S. G., Kensler, T. W., Askin, F. B., Rodenhuis, S., and Hruban, R. H. (1993) K-ras oncogene activation in lung adenocarcinomas from former smokers. Cancer 72, 432-438.
269. You, M., Candrian, U., Maronpot, R. R., Stoner, G. D., and Anderson, M. W. (1989) Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. U.S.A. 86, 3070-3074.
270. Singer, B., and Essigmann, J. M. (1991) Site-specific mutagenesis: retrospective and prospective. Carcinogenesis 12, 949-955.
271. Moriya, M. (1993) Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted G•C→TA transversions in simian kidney cells. Proc. Natl. Acad. Sci. U.S.A. 90, 1122-1126.
272. Moriya, M., Zhang, W., Johnson, F., and Grollman, A. P. (1994) Mutagenic potency of exocyclic DNA adducts: Marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. U.S.A. 91, 11899-11903.
273. Nesnow, S., Ross, J. A., Stoner, G. D., and Mass, M. J. (1995) Mechanistic linkage between DNA adducts, mutations in oncogenes and tumorigenesis of carcinogenic environmental polycyclic aromatic hydrocarbons in strain A/J mice. Toxicology 103, 403-413.
274. Hecht, S. S., Rivenson, A., Braley, J., DiBello, J., Adams, J. D., and Hoffmann, D. (1986) Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res. 46, 4162-4166.
275. Lijinsky, W., Thomas, B. J., and Kovatch, R. M. (1991) Local and systemic carcinogenic effects of alkylating carcinogens in rats treated by intravesicular administration. Jpn. J. Cancer Res. 82, 980-986.
276. Hjinsky, W., Saavedra, J. E., and Kovatch, R. M. (1991) Carcinogenesis in rats by substituted dialkylnitrosamines given by gavage. In Vivo 5, 85-89.
277. Prokopczyk, B., Rivenson, A., and Hoffmann, D. (1991) Comparative carcinogenicity of 3-(methylnitrosamino)propionitrile and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone upon local application to mouse skin and rat oral mucosa. Cancer Lett. 60, 153-157.
278. Hoffmann, D., Rivenson, A., Abbi, R., and Wynder, E. (1993) Effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res. 53, 2758-2761.
279. Nachiappan, V., Mufti, S. I., Chakravarti, A., Eskelson, C. D., and Rajasedkharan, R. (1994) Lipid per oxidation and ethanolrelated tumor promotion in Fischer-344 rats treated with tobacco-specific nitrosamines. Alcohol Alcohol. 29, 565-574.
280. Boorman, G. A., Hailey, R., Grumbein, S., Chou, B. J., Herbert, R. A., Goehl, T., Mellick, P. W., Roycrofl, J. H., Haseman, J. K., and Sills, R. (1994) Toxicology and carcinogenesis studies of ozone and 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1-butanone in Fischer-344/N rats. Toxicol. Pathol. 22, 545-554.
281. Chung, F.-L., Kelloff, G., Steele, V., Pittman, B., Zang, E., Jiao, D., Rigotty, J., Choi, C.-L, and Rivenson, A. (1996) Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res. 56, 772-778.
282. LaVoie, E. J., Prokopczyk, G., Rigotty, J., Czech, A., Rivenson, A., and Adams, J. D. (1987) Tumorigenic activity of the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (iso-NNAL) and N′-nitrosonornicotine (NNN) on topical application to Sencar mice. Cancer Lett. 37, 277-283.
283. Hecht, S. S., Abbaspour, A., and Hoffmann, D. (1988J Bioasaay in A/J mice of some structural analogues of tobacco-specific nitrosamines. Cancer Lett, 42, 141-145.
284. Padma, P. R., Lalitha, V. S., Amonkar, A. J., and Bhide, S. V. (1989) Anticarcinogenic effect of betel leaf extract against tobacco carcinogens. Cancer Lett. 45, 195-202.
285. Morse, M. A., Eklind, K. I., Amin, S. G., Hecht, S. S., and Chung, F.-L. (1989) Effects of alkyl chain length on the inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. Carcinogenesis 10, 1757-1759.
286. Rivenson, A., Djordjevic, M. V., Amin, S., and Hoffmann, D. (1989) Bioassay in A/J mice of some W-nitrosamines. Cancer Lett. 47, 111-114.
287. Anderson, L. M., Hecht, S. S., Dixon, D. E., Dove, L. F., Kovatch, R. M., Amin, S., Hoffmann, D., and Rice, J. M. (1989) Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Cancer Res. 49, 3770-3775.
288. Morse, M. A., Reinhardt, J. C., Amin, S. G., Hecht, S. S., Stoner, G. D., and Chung, F.-L. (1990) Effect of dietary aromatic isothiocyanates fed after the administration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone on lung tumorigenicity in mice. Cancer Lett. 49, 225-230.
289. Wattenberg, L. W., and Coccia, J. B. (1991) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone carcinogenesis in mice by D-limonene and citrus fruit oils. Carcinogenesis 12, 115-117.
290. Gunning, W. T., Castonguay, A., Goldblatt, P. J., and Stoner, G. D. (1991) Strain A/J mouse lung adenoma growth patterns vary when induced by different carcinogens. Toxicol. Pathol. 19, 168-175.
291. Anderson, L. M., Hecht, S. S., Kovatch, R. M., Amin, S., Hoffmann, D., and Rice, J. M. (1991) Tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in infant mice. Cancer Lett. 58, 177-181.
292. Castonguay, A., Pepin, P., and Stoner, G. D. (1991) Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp. Lung Res. 17, 485-499.
293. Jalbert, G., and Castonguay, A. (1992) Effects of NSAIDS on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett. 66, 21-28.
294. Wang, Z. Y., Hong, J.-Y., Huang, M.-T., Reuhl, K. R., Conney, A. H., and Yang, C. S. (1992) Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 52, 1943-1947.
295. Morse, M. A., Eklind, K. I., Amin, S. G., and Chung, F. L. (1992) Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Lett. 62, 77-81.
296. Boukharta, M., Jalbert, G., and Castonguay, A. (1992) Biodistribution of ellagic acid and dose-related inhibition of lung tumorigenesis in A/J mice. Nutr. Cancer 18, 181-189.
297. Belinsky, S. A., Stefanski, S. A., and Anderson, M. W. (1993) The A/J mouse lung as a model for developing new chemointervention strategies. Cancer Res. 53, 410-416.
298. El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., and Hecht, S. S. (1993) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenicity in mouse lung by the synthetic organoselenium compound, 1,4-phenylenebis(methylene)- selenocyanate. Carcinogenesis 14, 1111-1113.
299. Alworth, W. L., Young-Sciame, R., and Hecht, S. S. (1993) Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone mouse lung tumorigenesis by arylalkynes, mechanism-based inactivators of cytochrome P-450. Carcinogenesis 14, 1711-1713.
300. Beebe, L. E., Kim, Y. E., Amin, S., Riggs, C. W., Kovatch, R. M., and Anderson, L. M. (1993) Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N nitrosodimethylamine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254). Carcinogenesis 14, 1545-1548.
301. Hoffmann, D., Djordjevic, M. V., Rivenson, A., Desai, D., and Amin, S. (1993) Relative potencies of tobacco-specific N-nitrosamines as inducers of lung tumors in A/J mice. Cancer Lett, 71, 25-30.
302. Jiao, D., Eklind, K. T., Choi, C. I., Desai, D. H., Amin, S. G., and Chung, F. L. (1994) Structure- activity relationships of isothiocyanates as mechanism-based inhibitors of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Res. 54, 4327-4333.
303. Hecht, S. S., Isaacs, S., and Trushin, N. (1994) Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene; a potentially useful model for evaluation of chemopreventive agents. Carcinogenesis 15, 2721-2725.
304. El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., Hoffmann, D., and Wynder, E. L. (1996) Effects of 1,4-phenylenebis-(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res. 16, 2709-2712.
305. Wattenberg, L. W., and Estensen, R. D. (1996) Chemopreventive effects of myo-mositol and dexamethasone on benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary carcinogenesis in female A/J mice. Cancer Res. 56, 5132-5135.
306. Desai, D., Chang, L., and Amin, S. (1996) Synthesis and bioassay of 4-ipomeanol analogues as potential chemopreventive agents against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induced tumorigenicity in A/J mice. Canner Lett. 108, 263-270.
307. Finch, G. L., Nikula, K. J., Belinsky, S. A., Barr, E. B., Stoner, G. S., and Lechner, J. F. (1996) Failure of cigarette smoke to induce or promote lung cancer in the A/J mouse. Cancer Lett. 99, 161-167.
308. Yang, G.-Y., Wang, Z.-Y., Kim, S., Liao, J., Serril, D. N., Chen, X., Smith, T. J., and Yang, C. S. (1997) Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. Cancer Res. 57, 1889-1894.
309. Castonguay, A., and Rioux, N. (1997) Inhibition of lung tumorigenesis by sulindac: comparison of two protocols. Carcinogenesis 18, 491-496.
310. Hecht, S. S., Adams, J. D., Numoto, S., and Hoffmann, D. (1983) Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation. Carcinogenesis 4, 1287-1290.
311. Padma, P. R., Lalitha, V. S., Amonkar, A. J., and Bhide, S. V. (1989) Carcinogenicity studies on the two tobacco-specific N-nitrosamines, N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis 10, 1997-2002.
312. Correa, E., Joshi, P. A., Castonguay, A., and Schüller, H. M. (1990) The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res. 50, 3435-3438.
313. Schüller, H. M., Witschi, H.-P., Nylen, E., Joshi, P. A., Correa, E., and Becker, K. L. (1990) Pathobiology of lung tumors induced in hamsters by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the modulating effect of hyperoxia. Cancer Res. 50, 1960-1965.
314. Park, N.-H., Min, B.-M., Li, S.-L., Cherrick, H. M., and Doniger, J. (1993) Role of viruses in oral Carcinogenesis. Smoking and Tobacco Control Monograph 2, NIH Publ. No. 93-3461, pp 202-215, NIH, Bethesda, MD.
315. Schüller, H. M., Jorquera, R., Reichert, A., and Castonguay, A. (1993) Transplan cental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, Cancer Res. 53, 2498-2501.
316. Furukawa, F., Nishikawa, T., Yoshimura, H., Mitsui, M., Imazawa, T., Ikezaki, S., and Takahashi, M. (1994) Effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on N-nitrosobia(2-oxopropyl)amine (BOP)-initiated Carcinogenesis in hamsters. Cancer Lett. 86, 75-82.
317. Schüller, H. M., Jorquera, R., Lu, X., Riechert, A., and Castonguay, A. (1994) Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered sub- cutaneously or intratracheally to hamsters. J. Cancer Res. Clin Oncol. 120, 200-203.
318. Chen, Y.-P., Johnson, G. K., and Squier, C. A. (1994) Effects of nicotine and tobacco-specific nitrosamines on hamster cheek pouch and gastric mucosa. J. Oral Pathol. Med. 23, 251-255.
319. Sunday, M. E., Willet, C. G., Graham, S. A., Oreffo, V. I. C., Linnoila, R. I., and Witschi, H. (1995) Histochemical characterization of nonneuroendocrine tumors and neuroendocrine cell hyperplasia induced in hamster lung by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone with or without hyperoxia. Am. J Pathol 147, 740-751.
320. Furukawa, F., Nishikawa, T., Enami, T., Mitsui, M., Imazawa, T., Tanakamara, Z., Kim, H.-C., Lee, I.-S., Kasahara, K., and Takahashi, M. (1997) Promotional effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) on N-nitrosobis (2-oxopropyl) amine (BOP)-initiated carcinogenesis in hamsters. Food Chem. Toxicol. 35, 387-392.
321. Koppang, N., Rivenson, A., Dahle, H. K., and Hoffmann, D. (1997) Carcinogenicity of N′-nitrosonornicotine (NNN) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mink (Mustala vison). Cancer Lett. 111, 167-171.
322. Hecht, S. S. (1997) Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect. 105, (Suppl. 4), 955-963,
323. Prokopczyk, B., Amin, S., Desai, D. H., Kurtzke, C., Upadhyaya, P., and El-Bayoumy, K. (1997) Effects of 1,4-phenylenebis-(methylene)selenocyanate and selenemethionine on 4-(meth- ylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mouse lung. Carcinogenesis 18, 1855-1857.
324. Hawk, M, A., Cesen, K. T., Siglin, J. C., Stoner, G. D., and Ruch, R. J. (1996) Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastation. Cancer Lett, 109, 217-222.
325. Bilodeau, J.-F., Wang, M., Chung, F.-L., and Castonguay, A. (1995) Effects of nonsteroidal antiflammatory drugs on oxidation pathways in A/J mice. Free Radicals Biol. Med. 18, 47-54.
326. Rioux, N., and Castonguay, A. (1997) Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal antiinflammatory drugs. J. Natl Cancer Inst. 89, 874-880.
327. Padma, P. R., Amonkar, A. J., and Bhide, S. V. (1989) Mutagenic and cytogenetic studies of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Lett. 46, 173-180.
328. Padma, P. R., Amonkar, A. J., and Bhide, S. V. (1989) Antimutagenic effects of betel leaf extract against the mutagenicity of two tobacco-specific N-nitrosamines. Mutagenesis 4, 154-156.
329. Amonkar, A. J., Padma, P. R., and Bhide, S. V. (1989) Protective effect of hydroxychavicol, a phenolic component of betel leaf against the tobacco-specific carcinogens. Mutat. Res. 210, 249-253.
330. Dahl, J. E., Becher, R., Lag, M., Schuller, H. M., and Dybing, E. (1990) Formation of genotoxic products from N-nitrosoheptamethyleneimine (NHMI), 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone (NNK) and N′-nitrosonornicotine (NNN) by isolated rabbit lung cells. Cell Biol. Toxicol 6, 399-409.
331. Zhu, S. Y., Cunningham, M. L., Gray, T. E., and Nettesheim, P. (1991) Cytotoxicity, genotoxicity and transforming activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat tracheal epithelial cells. Mutat. Res. 261, 249-259.
332. Teel, R. W., and Castonguay, A. (1992) Antimutagenic effects of polyphenolic compounds. Cancer Lett. 66, 107-113.
333. Teel, R. W. (1992) Effect of different inducers of cytochrome P450 on the mutagenesis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium TA1535. Anticancer Res. 12, 1287-1290.
334. Romert, L., Corvall, M., and Jenssen, D. (1992) Chlorophyllin is both a positive and negative modifier of mutagenicity. Mutagenesis 7, 349-355.
335. Espinosa-Aguirre, J. J., Vilchis, C., Ostrosky-Wegman, P., Benitez, L., Lares, I., and Rubio, J. (1993) Antimutagenicity of cyclohexanol towards 4-(N-nitrosomethylamino)-1-(3-pyridyl)-1butanone and N-nitrosodiethylamine. Mutat. Res, 300, 151-154.
336. Teel, R. W. (1993) Effect of phytochemicals on the mutagenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in Salmonella typhimurium strain TA1535. Phytother. Res. 7, 248-251.
337. DeFlora, S., Belansky, R., Gaspirini, L., and Camoirano, A. (1995) Bacterial mutagenicity of cigarette smoke and its interaction with ethanol. Mutagenesis 10, 47-52.
338. Lee, C. K., Fulp, C., Rombick, B. R., and Doolittle, D. J. (1996) Inhibition of mutagenicity of N-nitrosamines by tobacco smoke and its constituents. Mutat. Lett. 367, 83-92.
339. Kolar, C., and Lawson, T. (1997) Mutagenicity of carcinogenic nitrosamines when activated by hamster and human pancreatic duct epithelial cells. Cancer Lett, 117, 149-154,
340. Williams, G. M., and Laspia, M. F. (1979) The detection of various nitrosamines in the hepatocyte primary culture/DNA repair test. Cancer Lett. 6, 199-206.
341. Alaoui-Jamali, M. A., Castonguay, A., and Schuller, H. M. (1988) In vitro genotoxicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1butanone activated by hamster maternal and fetal tissues. Carcinogenesis 9, 2319-2324.
342. Zimonjic, D., Popescu, N. C., and DiPaolo, J. A. (1989) Induction of sister-chromatid exchanges by tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human and hamster cells. Carcinogenesis 10, 753-755.
343. Pohlmann, C., Koops, F., Berg, J., Holz, O., Ehlert, U., and Rüdiger, H. W. (1992) Determinants of a genotoxic effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human diploid fibroblasts. Clin. Invest, 70, 295-298.
344. Swedmark, S., Romert, L., Beije, B., Diaz-Pohl, C., Backbro, A., and Jenssen, D. (1994) Comparison of co-cultivation of V79 cells with rat hepatocytes and rat H4IIE hepatoma cells for studying nitrosamine-induced hprt gene mutations. Mutagenesis 9, 281-287.
345. Knasmuller, S., Kassie, F., Zohrer, E., Kundi, M., McCoy, G. D., and Schulte-Hermann, R. (1994) Effects of ethanol treatment on DNA damage induced in Escherichia coli K-12 in various organs of mice by N-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosopyrrolidine, Carcinogenesis 15, 263-270.
346. Kim, P. M., and Wells, P. G. (1996) Genoprotection by UDP-glucucuronyltransferases in perioxidase-dependent, reactive oxygen species-mediated micronucleus initiation by the carcinogens 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and benzo[a]pyrene. Cancer Res, 56, 1526-1532.
347. 3H]thymidine incorporation into DNA by carcinogenic N-nitrosamines. Mutat. Res. 149, 495-503.
348. Zhu, S., Gray, T. E., and Nettesheim, P. (1992) The effect of sodium selenate on cell proliferation and transformation of primary rat tracheal epithelial cells. Carcinogenesis 13, 1725-1729.
349. Klein-Szanto, A. J. P., Iizasa, T., Momiki, S., Garcia-Palazzo, I., Caamano, J., Metcalf, R., Welsh, J., and Harris, C. C. (1992) A tobacco-specific N-nitrosamine or cigarette smoke condensate causes neoplastic transformation of xenotransplanted human bronchial epithelial cells. Proc. Natl Acad. Sci. U.S.A. 89, 6693-6697.
350. Baskaran, K., Laconi, S., and Reddy, M. K. (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15, 2461-2466.
351. Langenfeld, J., Lonardo, F., Kiyokawa, H., Passalaris, T., Ahn, M.-J., Rusch, V., and Dmitrovsky, E. (1996) Inhibited transformation of immortalized human bronchial epithelial cells by retinoic acid is linked to cyclin E down-regulation. Oncogene 13, 1983-1990.
352. Tjälve, H., Castonguay, A., and Rivenson, A. (1985) Microautoradiographic localization of bound metabolites in the nasal cavities of F-344 rats treated with the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. J. Natl. Cancer Inst. 74, 185-189.
353. Hoss, W., Lin, J.-P. F., Matchett, S., and Davies, B. D. (1986) Characterization of noncholinergic nicotine receptors on human granulocytes. Biochem. Pharmacol. 35, 2367-2372.
354. Gijare, P. S., Rao, K. V. K., and Bhide, S. V. (1989) Effects of tobacco-specific nitrosamines and snuff extract on cell proliferation and activities of ornithine decarboxylase and aryl hydrocarbon hydroxylase in mouse tongue primary epithelial cell cultures. J. Cancer Res. Clin. Oncol. 115, 558-563.
355. Joshi, P. A., Schuller, H. M., Rossignol, G., and Castonguay, A. (1989) In vitro morphological changes induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal hamster respiratory tract tissue. Cancer Lett. 44, 173-178.
356. Schüller, H. M., and Hegedus, T. J. (1989) Effects of endogenous and tobacco-related amines and nitrosamines on cell growth and morphology of a cell line derived from a human neuroendocrine lung cancer. Toxicol. in Vitro 3, 37-43.
357. Schüller, H. (1989) Cell type specific, receptor-mediated modulation of growth kinetics in human lung cancer cell lines by nicotine and tobacco-related nitrosamines. Biochem. Pharmacol. 38, 3439-3439.
358. Schüller, H. M., and Cole, B. (1989) Regulation of cell proliferation by β-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 10, 1753-1755.
359. Padma, P. R., Amonkar, A. J., and Bhide, S. V. (1991) Effect of long-term treatment of two tobacco-specific N-nitrosamines on the vitamin A status of mice. Nutr. Cancer 15, 217-220.
360. Murrah, V. A., Gilchrist, E. P., and Moyer, M. P. (1993) Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture. Oral Surg. Oral Med. Oral Pathol. 75, 324-332.
361. Sunday, M. E., Willett, C. G., Patidar, K., and Graham, S. A. (1994) Modulation of oncogene and tumor suppression gene expression in a hamster model of chronic lung injury with varying degrees of pulmonary neuroendocrine cell hyperplasis. Lab. Invest. 70, 875-888.
362. Schußller, H. M. (1994) Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent mitogenic pathways. Neurotoxicology 15, 877-886.
363. Hu, G., Han, C., and Chen, J. (1995) Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. Nutr. Cancer. 24, 203-209.
364. Issa, J.-P. J., Baylin, S. B., and Belinsky, S. A. (1996) Methylation of the estrogen receptor CpG island in lung tumors is related to the specific type of carcinogen exposure. Cancer Res. 56, 3655-3658.
365. Fuchs, S. Y., and Ronai, Z. (1996) Elevated binding to VRE/ PEBP2 during the late stages of NNK and benzo[a]pyreneinduced carcinogenesis in A/J mice. Cancer Lett. 102, 101-106.
366. Lyng, F. M., de Feijter-Rupp, H. L., Hayashi, T., O'Malley, K., Murphy, D. M., Cottell, D. C., Trosko, J. E., Seymour, C. B., and Mothersill, C. (1996) Effect of a tobacco-related nitrosamine on intercellular communication in human urothelial cells: a possible factor in smoking-related bladder carcinogenesis. Oncol. Res. 8, 371-378.
367. Penn, A., and Snyder, C. A. (1996) 1,3-Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation 93, 552-557.
368. Belinsky, S. A., Swafford, D. S., Middleton, S. K., Kennedy, C. H., and Tesfaigzi, J. (1997) Deletion and differential expression of p16INK4a in mouse lung tumors. Carcinogenesis 18, 115-129.
369. Dokko, H., Min, P. S., Cherrick, H. M., and Park, N.-H. (1991) Effect of smokeless tobacco and tobacco-related chemical carcinogens on survival of ultraviolet light-inactivated herpes simplex virus. Oral Surg. Med. Oral Pathol. 71, 464-468.
370. Park, N.-H., Dokko, H., Li, S.-L., and Cherrick, H. M. (1991) Synergism of herpes simplex virus and tobacco-specific N′-nitrosamines in cell transformation. J. Oral Maxillofac. Surg. 49, 276-281.
371. Larsson, P.-A., Hirsch, J. M., Gronowitz, J. S., and Vahlne, A. (1992) Inhibition of Herpes simplex virus replication and protein synthesis by nonsmoked tobacco, tobacco alkaloids and nitrosamines. Arch. Oral Biol. 37, 969-978.
372. Kim, M. S., Shin, K.-H., Baek, J.-H., Cherrick, H. M., and Park, N.-H. (1993) HPV-16, tobacco-specific N-nitrosamine, and N-methyl-N′-nitro-N-nitrosoguanidine in oral carcinogenesis. Cancer Res. 53, 4811-4816.
373. Lindemann, R. A., and Park, N.-H. (1989) The effects of benzo[a]pyrene, nicotine and tobacco-specific N-nitrosamines in the generation of human lymphokine-activated killer cells. Arch. Oral Biol. 34, 283-287.
374. Chen, C. B., Hecht, S. S., and Hoffmann, D. (1978) Metabolic α-hydroxylation of the tobacco specific carcinogen, N′-nitrosonornicotine. Cancer Res. 38, 3639-3645.
375. Chen, C. B., Fung, P. T., and Hecht, S. S. (1979) Assay for microsomal α-hydroxylation of N′-nitrosonornicotine and determination of the deuterium isotope effect for α-hydroxylation. Cancer Res. 39, 5057-5062.
376. Hecht, S. S., Chen, C. B., and Hoffmann, D. (1980) Metabolic β-hydroxylation and N-oxidation of N′-nitrosonornicotine. J. Med. Chem. 23, 1175-1178.
377. McCoy, G. D., Chen, C. B., and Hecht, S. S. (1981) Influence of mixed function oxidase inducers on the in vitro metabolism of N′-nitrosonornicotine by rat and hamster liver microsomes. Drug Metab. Dispos. 9, 168-169.
378. Hecht, S. S., Reiss, B., Lin, D., and Williams, G. M. (1982) Metabolism of N′-nitrosonornicotine by cultured rat esophagus. Carcinogenesis 3, 453-456.
379. Hecht, S. S., and Young, R. (1982) Regiospecificity in the metabolism of the homologous cyclic nitrosaminea, N′-nitrosonornicotine and AP-nitrosoanabasine. Carcinogenesis 3, 1195-1199.
380. Chung, F.-L., Juchatz, A., Vitarius, J., and Hecht, S. S. (1984) Effects of dietary compounds on β-hydroxylation of N-nitrosopyrrolidine and N′-nitrosonornicotine in rat target tissues. Cancer Res. 44, 2924-2928.
381. Castonguay, A., Rivenson, A., Trushin, N., Reinhardt, J., Spathopoulos, S., Weiss, C. J., Reiss, B., and Hecht, S. S. (1984) Effects of chronic ethanol consumption on the metabolism and carcinogenicity of N′-nitrosonornicotine in F344 rats. Cancer Res. 44, 2285-2290.
382. Murphy, S. E., and Spina, D. A. (1994) Evidence for a high affinity enzyme in rat esophageal microsomes which α-hydroxylates N′-nitrosonornicotine. Carcinogenesis 15, 2709-2713.
383. Autrup, H., Harris, C. C., and Trump, B. F. (1978) Metabolism of ayclic and cyclic N-nitrosamines by cultured human colon. Proc. Soc. Exp. Biol. Med. 159, 111-115.
384. Hecht, S. S., Chen, C. B., McCoy, G. D., Hoffmann, D., and Domellöf, L. (1979) α-Hydroxylation of N-nitrosopyrrolidine and N′-nitrosonornicotine by human liver microsomes. Cancer Lett, 8, 35-41.
385. Chakradeo, P. P., Nair, J., and Bhide, S. V. (1995) Metabolism of N′-nitrosonornicotine by adult and fetal human oesophageal cultures. Cell Biol. Int. 19, 53-58.
386. Patten, C., Smith, T., Friesen, M., Tynes, R., Yang, C., and Murphy, S. (1997) Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N′-nitrosonornicotine α-hydroxylation by human liver microsomes. Carcinogenesis 18, 1623-1630.
387. Egashira, T., and Waddell, W. J. (1984) Histochemical localization of monoamine oxidase in whole-body, freezc-dried sections of mice. Histochemistry 16, 919-929.
388. McCoy, G. D., Katayama, S., Young, R., Wyatt, M., and Hecht, S. (1982) Influence of chronic ethanol consumption on the metabolism and carcinogenicity of tobacco-related nitrosamines. In N-Nitroso Compounds; Occurrence and Biological Effects (Bartsch, H., O'Neill, I. K., Castegnaro, M., Okada, M., and Davis, W., Eds.) pp 635-642, International Agency for Research on Cancer, Lyon, France.
389. Nakajima, M., Yamamoto, T., Nunoya, K.-I., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., and Kuroiwa, Y. (1996) Role of human cytochrome P450 2A6 in C-oxidation of nicotine. Drug Metab, Dispos. 24, 1212-1217.
390. Egashira, T., and Waddell, W. J. (1984) Histochemical localization of primary and secondary alcohol dehydrogenases in wholebody, freeze-dried sections of mice. Histochemistry 16, 931-940.
391. Brittebo, E. B., and Tjälve, H. (1981) Formation of tissue-bound N′-nitrosonornicotine metabolites by the target tissues of Sprague-Dawley and Fisher rats. Carcinogenesis 2, 959-963.
392. Löfberg, B., Brittebo, E. B., and Tjälve, H. (1982) Localization and binding of N′-nitrosonornicotine metabolites in the nasal region and in some other tissues of Sprague-Dawley rats. Cancer Res. 42, 2877-2883.
393. 14C]-nitrosonornicotine in tissues of the mouse. Cancer Res. 40, 3518-3523.
394. 14C nitrosonornicotine in mice, J. Cancer Res. Clin. Oncol. 98, 233-242.
395. Waddell, W. J., and Marlowe, C. (1983) Inhibition by alcohols of the localization of radioactive nitrosonornicotine in sites of tumor formation. Science 221, 51-53.
396. Domellöf, L., Andersson, M., Tjälve, H., Veals, S., Trushin, N., and Hecht, S. S. (1987) Distribution and metabolism of N′-nitrosonornicotine in the miniature pig. Carcinogenesis 8, 1741-1747.
397. Chung, F.-L., Wang, M., and Hecht, S, S. (1989) Detection of exocyclic guanine adducts in hydroly sates of hepatic DNA of rats treated with N-nitrosopyrrolidine and in calf thymus DNA reacted with α-acetoxy-N-nitrosopyrrolidine. Cancer Res. 49, 2034-2041.
398. Wang, M., Chung, F.-L., and Hecht, S. S, (1992) Formation of 7-(4-oxobutyl)guanine in hepatic DNA of rats treated with N-nitrosopyrrolidine. Carcinogenesis 13, 1909-1911.
399. Wang, M., and Hecht, S. S. (1997) A cyclic N7, C-8 guanine adduct of N-nitrosopyrrolidine (NPYR): formation in nucleic acids and excretion in the urine of NPYR-treated rats. Chem. Res. Toxicol. 10, 772-778.
400. Lai, D. Y., Arcos, J. C., and Argus, M. F. (1980) Interaction of the tobacco-specific nitrosamines, metbylethylnitrosamine and N-nitrosonornicotine, with DNA and guanosine. Res. Commun. Chem. Pathol. Pharmacol. 28, 87-103.
401. Diaz Gómez, M. I., Tamayo, D., and Castro, J. A. (1986) Administration of N-nitrosodimethylamine, N-nitrosopyrrolidine, or N′-nitrosonornicotine to nursing rats: their interactions with liver and kidney nucleic acids from sucklings. J. Natl. Cancer Inst. 76, 1133-1136.
402. Hughes, M. F., Brock, W. J., and Vore, M. (1986) Characterization of covalent binding of N′-nitrosonornicotine in rat liver microsomes. Carcinogenesis 7, 3-8.
403. Schuster, G. S., Lubas, S., Erbland, J. F., and Singh, B. B. (1990) Binding and uptake of N-nitrosonornicotine by oral epithelial cells. J. Oral Pathol. Med. 19, 114-118.
404. Hoffmann, D., Raineri, R., Hecht, S. S., Maronpot, R., and Wynder, E. L. (1975) Effects of N′-nitrosonornicotine and N′-nitrosoanabasine in rats. J. Natl. Cancer Inst. 55, 977-981.
405. Singer, G. M., and Taylor, H. W. (1976) Carcinogenicity of N′-nitrosonornicotine in Sprague-Dawley rats. J. Natl. Cancer Inst. 57, 1275-1276.
406. Hecht, S. S., Young, R., Rivenson, A., and Hoffmann, D. (1982) On the metabolic activation of N-nitrosomorpholine and N′-nitrosonornicotine: effects of deuterium substitution. In N-Nitroso Compounds: Occurrence and Biological Effects (Bartsch, H., O'Neill, I. K., Castegnaro, M., Okada, M., and Davis, W., Eds.) pp 499-507, International Agency for Research on Cancer, Lyon, France.
407. Griciute, L., Castegnaro, M., Bereziat, J. C., and Cabral, J. R. P. (1986) Influence of ethyl alcohol on the carcinogenic activity of N-nitrosonornicotine. Cancer Lett. 31, 267-275.
408. Hoffmann, D., Hecht, S. S., Ornaf, R. M., Wynder, E. L., and Tso, T. C. (1976) Nitrosonornicotine: presence in tobacco, formation and carcinogenicity. In Environmental N-Nitroso Compounds: Analysis and Formation (Walker, E. A., Bogovski, P., and Griciute, L., Eds.) pp 307-320, International Agency for Research on Cancer, Lyon, France.
409. Deutsch-Wenzel, R. P., Brune, H., Grimmer, G., and Miafeld, J. (1985) Local application to mouse skin as a carcinogen specific test system for nonvolatile nitroso compounds. Cancer Lett. 29, 85-92.
410. Hilfrich, J., Hecht, S. S., and Hoffmann, D. (1977) Effects of N′-nitrosonornicotine and N′-nitrosoanabasine in Syrian golden hamsters. Cancer Lett. 2, 169-176.
411. McCoy, G. D., Hecht, S. S., Katayama, S., and Wynder, E. L. (1981) Differential effect of chronic ethanol consumption on the carcinogenicity of N-nitrosopyrrolidine and N′-nitrosonornicotine in male Syrian golden hamsters. Cancer Res. 41, 2849-2854.
412. Hecht, S. S., Young, R., and Maeura, Y. (1983) Comparative carcinogenicity in F344 rats and Syrian golden hamsters of N′-nitrosonornicotine and N′-nitrosonornicotine-1-N-oxide. Cancer Lett. 20, 333-340.
413. Altuwairgi, O. S., Papageorge, M. B., and Doku, H. C. (1995) The cancer-promoting effect of N-nitrosonornicotine used in combination with a subcarcinogenic dose of 4-nitroquinoline-N-oxide and 7,12-dimethylbenz(a)anthracene. J. Oral Maxillofac. Surg. 53, 910-913.
414. Papageorge, M. B., Cataldo, E., and Jahngen, E. G. E. (1996) The effect of N-nitrosonornicotine on the buccal mucosa of Syrian hamsters. J. Oral Maxillofac. Surg, 54, 187-190.
415. Koppang, N., Rivenson, A., Reith, A., Dahle, H. K., Evensen, O., and Hoffmann, D. (1992) Carcinogenicity of N′-nitrosonornicotine in mink (Mustela vison). Carcinogenesis 13, 1957-1960.
416. Hirota, N. (1979) Intranuclear rodlets in undifferentiated carcinomas of salivary glands in strain A mice in a study involving a tobacco-specific nitrosamine, N-nitrosonomicotine. Cancer Lett. 6, 365-369.
417. andrews, A. W., Thibault, L. H., and Lijinsky, W. (1978) The relationship between mutagenicity and carcinogenicity of some nitrosamines. Mutat. Res. 51, 319-326.
418. Bartsch, H., Malaveille, C., Camus, A.-M., Planche-Martel, G., Brun, G., Hautefeuille, A., Sabadie, N., Barbin, A., Kuroki, T., Drevon, C., Piccoli, C., and Montesano, R. (1980) Bacterial and mammalian mutagenicity tests: validation and comparative studies on 180 chemicals. IARC Scientif. Publ. 27, 179-241.
419. Gruetter, C. A., Barry, B. K., McNamara, D. B., Kadowitz, P. J., and Ignarro, L. J. (1980) Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N′-nitrosonornicotine and nitric oxide. J. Pharmacol. Exp. Ther. 214, 9-15.
420. Olson, J. W., and Crooks, P. A. (1985) Effect of nicotine and N′nitrosonornicotine on rat lung and trachea ornithine decarboxy-lase activity. Carcinogenesis 6, 1517-1519.
421. Squier, C. A. (1986) Enhanced penetration of nitrosonornicotine across oral mucosa in the presence of ethanol. J. Oral Pnthol. 15, 276-279.
422. Schuster, G. S., Erbland, J. F., Wyrick, S. D., and Singh, B. B. (1986) Oral epithelial cell lipid synthesis in the presence of retinoic acid or nitrosonornicotine. Oral Pathol. 15, 430-433.
423. Squier, C. A. (1986) Penetration of nicotine and nitrosonornicotine across porcine oral mucosa. J. Appl. Toxicol. 6, 123-128.
424. Schuster, G. S., Erbland, J. F., Wyrick, S. D., and Singh, B. B. (1988) Phorbol ester binding to oral epithelial cells in the presnece of retinoic acid or N-nitrosonornicotine, Cytobios 54, 53-60.
425. Ammigan, N., Nair, U. J., Amonkar, A. J., and Bhide, S. V. (1989) Modulations in the biotransformation of tobacco extract and N′-nitrosonornicotinc under differential dietary protein status. J. Biochem. Toxicol. 4, 7-13.
426. Ammigan, N., Nair, U. J., Amonkar, A. J., and Bhide, S. V. (1990) Effect of tobacco extract and N′-nitrosonornicotine on the carcinogen metabolizing enzymes under dietary vitamin B status. Cancer Lett. 52, 153-159.
427. Ammigan, N., Nagabhushan, M., Nair, U. J., Amonkar, A. J., and Bhide, S. V. (1990) Effect of nutritional status on mutagenicity of urine excreted by rats treated with standard/experimental carcinogens. Indian J. Exp. Biol. 28, 711-713.
428. Schuster, G., Caughman, G. B., and Dirksen, T. R. (1995) Alteration of epithelial cell lipid synthesis by N-nitrosonornicotine. In Vitro Cell. Dev. 31, 295-299.
429. Djordjevic, M. V., Brunnemann, K. D., and Hoffmann, D. (1989) Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis 10, 1725-1731.
430. Pachinger, A., Begutter, H., Ultach, I., and Hlus, H. (1993) Determination of 4-(methylnitrosarnino)-4-(3-pyridyl,)butyric acid in tobacco, tobacco smoke and the urine of rats and smokers. J. Chromatogr. Biomed. Appl. 620, 55-60.
431. Tricker, A. R., Scherer, G., Conze, C., Adlkofer, F., Pachinger, A., and Klus, H. (1993) Evaluation of 4-(N-methylnitrosamino)4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites. Carcinogenesis 14, 1409-1414.
432. Ross, J. A., Nelson, G. B., Wilson, K. H., Rabinowitz, J. R., Galati, A., Stoner, G. D., Nesnow, S., and Mass, M. J. (1995) Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res. 55, 1039-1044.
433. Deutsch-Wenzel, R., Brune, H., and Grimmer, G. (1983) Experimental studies in rat lungs on the carcinogenicity and dose-response relationships of eight frequently occurring environmental polycyclic aromatic hydrocarbons. J. Natl. Cancer Inst. 71, 539-544.
434. Wolterbeek, A. P. M., Schoevers, E. J., Rutten, A. A. J. J. L., and Feron, V. J. (1995) A critical appraisal of intratracheal instillation of benzo[a]pyrene to Syrian golden hamsters as a model in respiratory tract carcinogenesis. Cancer Lett. 89, 107-116.
435. Gerde, P., Muggenburg, B., Thornton-Marming, J., Lewis, J., Pyon, K., and Dahl, A. (1997) Benzo[a]pyrene at an environmentally relevant dose is slowly absorbed by, and extensively metabolized in, tracheal epithelium. Carcinogenesis 18, 1825-1832.
436. Alexandrov, K., Rojas, M., Geneste, O., Castegnaro, M., Camus, A.-M., Petruzzelli, S., Giuntini, C., and Bartsch, H. (1992) An improved fluorometric assay for dosimetry of benzo[a]pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52, 6248-6253.
437. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
438. Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pryene adducts at lung cancer mutational hot spots in P53. Science 274, 430-432.
439. Hoffmann, D., Rivenson, A., Murphy, S. E., Chung, F.-L., Amin, S., and Hecht, S. S. (1993) Cigarette smoking and adenocarcinoma of the lung: the relevance of nicotine-derived N-nitrosamines. J. Smoking-Related Disorders 4, 165-189.
440. Devesa, S. S., Shaw, G., and Blot, W. J. (1991) Changing patterns of lung cancer incidence by histological type. Cancer Epidemiol., Biomarkers Prev. 1, 29-34.
441. Carmella, S., Borukhova, A., Desai, D., and Hecht, S. S. (1997) Evidence for endogenous formation of tobacco-specific nitrosamines from nicotine and other tobacco alkaloids in rats. Carcinogenesis 18, 101-106.
442. Österdahl, B.-G. (1990) The migration of tobacco-specific nitrosamines into the saliva of chewers of nicotine-containing chewing gum. Food Chem. Toxicol. 28, 619-622.
443. Parsons, W. D., Carmella, S. G., Akerkar, S., Bonilla, L. E., and Hecht, S. S. (1998) A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol., Biomarkers Prev. 7, 257-260.
444. Perera, F. P. (1997) Environment and cancer: who are susceptible? Science 278, 1068-1073.
445. Prokopczyk, B., Cox, J. E., Hoffmann, D., and Waggoner, S. E. (1997) Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers. J. Natl. Cancer Inst. 89, 868-873.